Award
NIH Reporter #5R21DK139543-02
Development of selective degradation strategies towards mutant transcription factors
Recipient
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Award Amount
$211,250.00
Ceiling
$211,250.00
Awarded
August 07, 2025
Identifier
5R21DK139543-02
Award for developing selective degradation strategies targeting mutant transcription factors, funded by NIH/NIDDK with a focus on rare genetic and hematological diseases.
Description
The project involves developing strategies for degrading mutant transcription factors. It is funded by NIH/NIDDK under grant PAR-23-119 and focuses on genetic and hematological rare diseases. The project duration is from September 1, 2025, to August 31, 2026.